The fine is likely to be the largest the Federal Trade Commission (FTC) has ever imposed on a technology company.
The fine: Facebook will pay the multibillion-dollar fine to settle an FTC investigation into its privacy practices, according to the Washington Post. The final sum is yet to be negotiated, but it will certainly dwarf a $22.5 million settlement with Google in 2012.
If talks break down, it could end in a bruising legal battle in court—and more negative headlines for Facebook. The FTC could also force Facebook to change its business practices as part of the settlement.
The probe: It began in March 2018 in the wake of the Cambridge Analytica scandal, in which the company improperly accessed data on 87 million Facebook users. The FTC is investigating whether Facebook’s behavior, plus various damaging revelations since, amounts to a violation of an agreement it reached with the agency in 2011 to improve its privacy practices.
Battles on many fronts: Facebook is currently contesting a fine of £500,000 ($641,000) imposed by the UK’s data protection watchdog in October 2018, insisting that no UK data was involved. It’s also fighting a lawsuit filed by the attorney general of the District of Columbia, which claims it misled users over data collection. Other investigations are under way in various US states.
Sign up here to our daily newsletter The Download to get your dose of the latest must-read news from the world of emerging tech.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.